|
MechanismEIF2B1 stimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Application |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Xili Technology (Shenzhen) Co., Ltd.
0 Patents (Medical) associated with Xili Technology (Shenzhen) Co., Ltd.
100 Deals associated with Xili Technology (Shenzhen) Co., Ltd.
100 Translational Medicine associated with Xili Technology (Shenzhen) Co., Ltd.